查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2020077

胰臟癌治療市場規模、佔有率、成長及全球產業分析：按類型、應用和地區分類，並預測至2026-2034年

Pancreatic Cancer Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 147 Pages | 商品交期: 請詢問到貨日

價格

胰臟癌治療市場的成長要素

由於癌症發病率上升和治療技術的進步，全球胰臟癌治療市場正經歷快速成長。預計該市場規模在2025年將達到38.2億美元，2026年將成長至44.2億美元，到2034年將達到144.3億美元，在預測期（2026-2034年）內複合年成長率高達15.95%。

憑藉先進的醫療保健基礎設施、高診斷率和主要企業的存在，預計到 2025 年，北美將以 47.5% 的市場佔有率主導市場。

胰臟癌仍然是全球最致命的癌症之一，發病率不斷上升，尤其是在老年族群中。隨著全球早期診斷水準的提高，對包括化療和標靶治療的有效治療方法的需求持續成長。

市場趨勢

影響胰臟癌治療市場的關鍵趨勢之一是對研發的日益重視。製藥公司正大力投資開發創新治療方法，包括標靶治療、免疫療法和個人化醫療。

正在研發和進行臨床試驗的藥物的湧現，正在加速治療方法的創新。例如，目前正在進行的mRNA疫苗和聯合治療的研究，在提高患者存活率方面顯示出令人鼓舞的成果。

此外，個人化醫療的趨勢正在加速發展，它能夠根據個人的基因譜量身定做治療方案，從而提高療效並減少副作用。

市場成長要素

胰臟癌發生率上升

胰臟癌病例在全球範圍內的增加是成長要素。吸煙、老化和生活方式的改變等因素都導致了發病率的上升。這使得對先進治療方案的需求日益成長。

擴大研發投入和增加新藥認證

研發投入的增加以及監管部門的頻繁核准，正在推動市場擴張。標靶治療和聯合免疫療法等新型治療方法正在提高存活率，並加速治療方法的普及應用。

診斷技術的進步

診斷技術的進步使得早期發現胰臟癌成為可能。診斷率的提高帶動了治療需求的成長，從而顯著促進了市場成長。

政府支持及宣傳計劃

政府為提高癌症意識和開展篩檢計畫的舉措，在擴大患者群體和滿足全球治療需求方面也發揮著至關重要的作用。

抑制因子

儘管預計市場將保持強勁成長，但也面臨諸多挑戰。高昂的治療費用仍然是一大障礙，尤其是在發展中地區。化療和標靶治療費用昂貴，限制了許多患者的治療機會。

此外，治療相關的副作用，例如噁心和疲勞，以及放射線治療的併發症，可能會阻礙患者選擇先進的治療方法。這些因素預計將在一定程度上抑制市場成長。

市場區隔分析

按類型

市場區隔將胰臟癌分為外分泌性胰臟癌和內分泌性胰臟癌。由於外分泌性胰臟癌發生率高，佔確診病例的絕大多數，因此佔市場主導地位。預計到2026年，其市佔率將維持在97.5%左右。

透過治療方法

從治療方法來看，市場可分為化療、放射線治療和其他療法。

  • 化療是市場上領先的一線治療方法，預計到 2026 年將佔 48.1% 的市佔率。
  • 由於精準技術的進步，放射線治療正受到越來越多的關注。

最終用戶

市場分為醫院、診所和其他機構。

  • 由於醫院擁有更完善的基礎設施和更先進的治療方法，因此在該領域佔主導地位，預計到 2026 年將佔 53.85% 的佔有率。
  • 隨著門診治療服務的增加，診所的數量也穩定增加。

區域趨勢

北美洲

北美在全球市場中處於領先地位，預計2025年市場規模將達到18.1億美元，2026年將達到21.1億美元。這一成長得益於先進的醫療保健系統和強大的藥物研發管線。

歐洲

預計到 2025 年，歐洲的市佔率將達到 10 億美元，到 2026 年將達到 11.4 億美元，這得益於人們意識的提高以及研發投入的增加。

亞太地區

亞太地區是一個快速成長的地區，預計到 2025 年市場規模將達到 7.7 億美元，到 2026 年將達到 9 億美元。這一成長是由醫療基礎設施的改善和癌症發病率的上升所推動的。

世界其他地區

在拉丁美洲、中東和非洲等地區，由於人們對醫療保健的認知和投資不斷提高，預計將出現溫和成長。

2026 年至 2034 年的複合年成長率為 15.95%。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 2025年主要國家及地區胰臟癌發生率
  • 產業重大發展動態－重大併購與合作
  • 胰臟癌診斷中使用的技術
  • 新冠疫情對全球胰臟癌治療市場的影響

第5章：2021-2034年全球胰臟癌治療市場分析、洞察與預測

  • 市場分析、洞察與預測：按類型
    • 外分泌
    • 內分泌
  • 市場分析、洞察與預測：按治療類型分類
    • 化療
    • 放射線治療
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院
    • 診所
    • 其他
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美胰臟癌治療市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲胰臟癌治療市場分析、洞察與預測（2021-2034年）

  • 國家
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區胰臟癌治療市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲胰臟癌治療市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲胰臟癌治療市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • AstraZeneca
    • Pfizer Inc.
    • Novartis AG
    • Genentech（F. Hoffmann-La Roche Ltd）
    • Bristol-Myers Squibb Company
    • Ipsen Pharma
    • Oncolytics Biotech, Inc.
    • TME Pharma
    • Erytech Pharma
Product Code: FBI101989

Growth Factors of pancreatic cancer treatment Market

The global pancreatic cancer treatment market is witnessing rapid growth due to the rising incidence of cancer and increasing advancements in treatment technologies. The market was valued at USD 3.82 billion in 2025 and is projected to grow to USD 4.42 billion in 2026, eventually reaching USD 14.43 billion by 2034, exhibiting a strong CAGR of 15.95% during the forecast period (2026-2034).

North America dominated the market with a 47.5% share in 2025, driven by advanced healthcare infrastructure, high diagnosis rates, and the presence of leading pharmaceutical companies.

Pancreatic cancer remains one of the deadliest cancers globally, with increasing cases particularly among the geriatric population. The demand for effective therapies, including chemotherapy and targeted drugs, continues to rise as early diagnosis improves worldwide.

Market Trends

One of the key trends shaping the pancreatic cancer treatment market is the growing focus on research and development (R&D). Pharmaceutical companies are investing heavily in developing innovative therapies, including targeted drugs, immunotherapies, and personalized medicine.

The emergence of pipeline drugs and clinical trials is accelerating treatment innovation. For example, ongoing studies on mRNA vaccines and combination therapies are showing promising outcomes in improving patient survival rates.

Additionally, the trend toward precision medicine is gaining traction, allowing treatments tailored to individual genetic profiles, which enhances effectiveness and reduces side effects.

Market Growth Drivers

Rising Prevalence of Pancreatic Cancer

The increasing number of pancreatic cancer cases globally is a major growth driver. Factors such as smoking, aging population, and lifestyle changes contribute to higher incidence rates. This has created a strong demand for advanced treatment solutions.

Increasing R&D and Drug Approvals

Growing investments in R&D and frequent approvals from regulatory authorities are boosting market expansion. Novel therapies such as targeted drugs and immunotherapy combinations are improving survival outcomes and driving adoption.

Advancements in Diagnosis

Improved diagnostic technologies are enabling early detection of pancreatic cancer. As diagnosis rates increase, the demand for treatment drugs rises, significantly contributing to market growth.

Government Support and Awareness Programs

Government initiatives promoting cancer awareness and screening programs are also playing a crucial role in expanding the patient pool and supporting treatment demand globally.

Restraining Factors

Despite strong growth, the market faces certain challenges. The high cost of treatment remains a major barrier, especially in developing regions. Chemotherapy and targeted therapies can be expensive, limiting accessibility for many patients.

Additionally, side effects associated with treatments, such as nausea, fatigue, and complications from radiation therapy, may discourage patients from opting for advanced therapies. These factors are expected to restrain market growth to some extent.

Market Segmentation Analysis

By Type

The market is segmented into exocrine and endocrine pancreatic cancer. The exocrine segment dominates due to its higher prevalence, accounting for the majority of diagnosed cases. It is expected to hold around 97.5% share in 2026.

By Treatment Type

Based on treatment, the market includes chemotherapy, radiation therapy, and others.

  • Chemotherapy leads the market as the first-line treatment, expected to account for 48.1% share in 2026.
  • Radiation therapy is gaining traction due to advancements in precision technologies.

By End-user

The market is divided into hospitals, clinics, and others.

  • Hospitals dominate the segment, with a projected 53.85% share in 2026, due to better infrastructure and availability of advanced treatment options.
  • Clinics are also growing steadily with increasing outpatient treatment services.

Regional Insights

North America

North America leads the global market, valued at USD 1.81 billion in 2025 and expected to reach USD 2.11 billion in 2026. Growth is driven by advanced healthcare systems and strong drug pipelines.

Europe

Europe accounted for USD 1.0 billion in 2025 and is projected to reach USD 1.14 billion in 2026, supported by rising awareness and increasing R&D investments.

Asia Pacific

Asia Pacific is a rapidly growing region, valued at USD 0.77 billion in 2025 and expected to reach USD 0.9 billion in 2026. Growth is fueled by improving healthcare infrastructure and rising cancer prevalence.

Rest of the World

Regions such as Latin America and the Middle East & Africa are experiencing gradual growth due to increasing awareness and healthcare investments.

Competitive Landscape

The market is highly competitive, with key players focusing on innovation and strategic collaborations. Major companies include AstraZeneca, Pfizer Inc., Novartis AG, Roche, and Bristol-Myers Squibb.

These companies are investing in new drug development, mergers, and partnerships to strengthen their market position. Continuous product approvals and pipeline advancements are intensifying competition.

Conclusion

The pancreatic cancer treatment market is poised for substantial growth, driven by rising cancer prevalence, advancements in treatment technologies, and increasing investment in R&D. With market value expected to grow from USD 3.82 billion in 2025 to USD 14.43 billion by 2034, the industry presents significant opportunities for stakeholders.

Growth Rate CAGR of 15.95% from 2026-2034

Segmentation

By Type

  • Exocrine
  • Endocrine

By Treatment Type

  • Chemotherapy
  • Radiation Therapy
  • Others

By End-user

  • Hospitals
  • Clinics
  • Others

By Region

  • North America (By Type, By Treatment Type, By End-user, and By Country)
    • U.S. (By Type)
    • Canada (By Type)
  • Europe (By Type, By Treatment Type, By End-user, and By Country/Sub-region)
    • Germany (By Type)
    • U.K. (By Type)
    • France (By Type)
    • Spain (By Type)
    • Italy (By Type)
    • Scandinavia (By Type)
    • Rest of Europe (By Type)
  • Asia Pacific (By Type, By Treatment Type, By End-user, and By Country/Sub-region)
    • Japan (By Type)
    • China (By Type)
    • India (By Type)
    • Australia (By Type)
    • Southeast Asia (By Type)
    • Rest of Asia Pacific (By Type)
  • Latin America (By Type, By Treatment Type, By End-user, and By Country/Sub-region)
    • Brazil (By Type)
    • Mexico (By Type)
    • Rest of Latin America (By Type)
  • Middle East & Africa (By Type, By Treatment Type, By End-user, and By Country/Sub-region)
    • GCC (By Type)
    • South Africa (By Type)
    • Rest of Middle East & Africa (By Type)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Incidence of Pancreatic Cancer, By Key Countries/Regions, 2025
  • 4.2. Key Industry Developments - Key Mergers, Acquisitions, and Partnerships
  • 4.3. Technologies used in the Diagnosis of the Pancreatic Cancer
  • 4.4. Impact of COVID-19 on the Global Pancreatic Cancer Treatment Market

5. Global Pancreatic Cancer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Exocrine
    • 5.1.2. Endocrine
  • 5.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 5.2.1. Chemotherapy
    • 5.2.2. Radiation Therapy
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals
    • 5.3.2. Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East and Africa

6. North America Pancreatic Cancer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Exocrine
    • 6.1.2. Endocrine
  • 6.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 6.2.1. Chemotherapy
    • 6.2.2. Radiation Therapy
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End-user
    • 6.3.1. Hospitals
    • 6.3.2. Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Type
    • 6.4.2. Canada
      • 6.4.2.1. By Type

7. Europe Pancreatic Cancer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Exocrine
    • 7.1.2. Endocrine
  • 7.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 7.2.1. Chemotherapy
    • 7.2.2. Radiation Therapy
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End-user
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. Germany
      • 7.4.1.1. By Type
    • 7.4.2. U.K.
      • 7.4.2.1. By Type
    • 7.4.3. France
      • 7.4.3.1. By Type
    • 7.4.4. Spain
      • 7.4.4.1. By Type
    • 7.4.5. Italy
      • 7.4.5.1. By Type
    • 7.4.6. Scandinavia
      • 7.4.6.1. By Type
    • 7.4.7. Rest of Europe
      • 7.4.7.1. By Type

8. Asia Pacific Pancreatic Cancer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Exocrine
    • 8.1.2. Endocrine
  • 8.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 8.2.1. Chemotherapy
    • 8.2.2. Radiation Therapy
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End-user
    • 8.3.1. Hospitals
    • 8.3.2. Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
      • 8.4.1.1. By Type
    • 8.4.2. China
      • 8.4.2.1. By Type
    • 8.4.3. India
      • 8.4.3.1. By Type
    • 8.4.4. Australia
      • 8.4.4.1. By Type
    • 8.4.5. Southeast Asia
      • 8.4.5.1. By Type
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Type

9. Latin America Pancreatic Cancer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Exocrine
    • 9.1.2. Endocrine
  • 9.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 9.2.1. Chemotherapy
    • 9.2.2. Radiation Therapy
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End-user
    • 9.3.1. Hospitals
    • 9.3.2. Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
      • 9.4.1.1. By Type
    • 9.4.2. Mexico
      • 9.4.2.1. By Type
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Type

10. Middle East & Africa Pancreatic Cancer Treatment Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Exocrine
    • 10.1.2. Endocrine
  • 10.2. Market Analysis, Insights and Forecast - By Treatment Type
    • 10.2.1. Chemotherapy
    • 10.2.2. Radiation Therapy
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End-user
    • 10.3.1. Hospitals
    • 10.3.2. Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC
      • 10.4.1.1. By Type
    • 10.4.2. South Africa
      • 10.4.2.1. By Type
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Type

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Pfizer Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Novartis AG
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Genentech (F. Hoffmann-La Roche Ltd)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Bristol-Myers Squibb Company
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Ipsen Pharma
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Oncolytics Biotech, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. TME Pharma
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Erytech Pharma
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 2: Global Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2021-2034
  • Table 3: Global Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 4: Global Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 6: North America Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2021-2034
  • Table 7: North America Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 8: North America Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: U.S. Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 10: Canada Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 11: Europe Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 12: Europe Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2021-2034
  • Table 13: Europe Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 14: Europe Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 15: Germany Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 16: U.K. Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 17: France Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 18: Spain Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 19: Italy Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 20: Scandinavia Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 21: Rest of Europe Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 22: Asia Pacific Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 23: Asia Pacific Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2021-2034
  • Table 24: Asia Pacific Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 25: Asia Pacific Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Japan Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 27: China Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 28: India Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 29: Australia Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 30: Southeast Asia Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 31: Rest of Asia Pacific Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 32: Latin America Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 33: Latin America Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2021-2034
  • Table 34: Latin America Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 35: Latin America Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 36: Brazil Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 37: Mexico Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 38: Rest of Latin America Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 39: Middle East & Africa Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 40: Middle East & Africa Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Treatment Type, 2021-2034
  • Table 41: Middle East & Africa Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 42: Middle East & Africa Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 43: GCC Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 44: South Africa Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 45: Rest of Middle East & Africa Pancreatic Cancer Treatment Market Revenue (USD billion) Forecast, by Type, 2021-2034

List of Figures

  • Figure 1: Global Pancreatic Cancer Treatment Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Pancreatic Cancer Treatment Market Value Share (%), by Type, 2025 & 2034
  • Figure 3: Global Pancreatic Cancer Treatment Market Value Share (%), by Treatment Type, 2025 & 2034
  • Figure 4: Global Pancreatic Cancer Treatment Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Pancreatic Cancer Treatment Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Pancreatic Cancer Treatment Market Value (USD billion), by Type, 2025 & 2034
  • Figure 7: North America Pancreatic Cancer Treatment Market Value Share (%), by Type, 2025
  • Figure 8: North America Pancreatic Cancer Treatment Market Value (USD billion), by Treatment Type, 2025 & 2034
  • Figure 9: North America Pancreatic Cancer Treatment Market Value Share (%), by Treatment Type, 2025
  • Figure 10: North America Pancreatic Cancer Treatment Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Pancreatic Cancer Treatment Market Value Share (%), by End-user, 2025
  • Figure 12: North America Pancreatic Cancer Treatment Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Pancreatic Cancer Treatment Market Value Share (%), By Country, 2025
  • Figure 14: Europe Pancreatic Cancer Treatment Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Pancreatic Cancer Treatment Market Value Share (%), by Type, 2025
  • Figure 16: Europe Pancreatic Cancer Treatment Market Value (USD billion), by Treatment Type, 2025 & 2034
  • Figure 17: Europe Pancreatic Cancer Treatment Market Value Share (%), by Treatment Type, 2025
  • Figure 18: Europe Pancreatic Cancer Treatment Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Pancreatic Cancer Treatment Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Pancreatic Cancer Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Pancreatic Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Pancreatic Cancer Treatment Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Pancreatic Cancer Treatment Market Value Share (%), by Type, 2025
  • Figure 24: Asia Pacific Pancreatic Cancer Treatment Market Value (USD billion), by Treatment Type, 2025 & 2034
  • Figure 25: Asia Pacific Pancreatic Cancer Treatment Market Value Share (%), by Treatment Type, 2025
  • Figure 26: Asia Pacific Pancreatic Cancer Treatment Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Pancreatic Cancer Treatment Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Pancreatic Cancer Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Pancreatic Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Pancreatic Cancer Treatment Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Pancreatic Cancer Treatment Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Pancreatic Cancer Treatment Market Value (USD billion), by Treatment Type, 2025 & 2034
  • Figure 33: Latin America Pancreatic Cancer Treatment Market Value Share (%), by Treatment Type, 2025
  • Figure 34: Latin America Pancreatic Cancer Treatment Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Pancreatic Cancer Treatment Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Pancreatic Cancer Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Pancreatic Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Pancreatic Cancer Treatment Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Pancreatic Cancer Treatment Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Pancreatic Cancer Treatment Market Value (USD billion), by Treatment Type, 2025 & 2034
  • Figure 41: Middle East & Africa Pancreatic Cancer Treatment Market Value Share (%), by Treatment Type, 2025
  • Figure 42: Middle East & Africa Pancreatic Cancer Treatment Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Pancreatic Cancer Treatment Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Pancreatic Cancer Treatment Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Pancreatic Cancer Treatment Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Pancreatic Cancer Treatment Market Share (%), By Company, 2025